Effectiveness and safety of nirmatrelvir + ritonavir in COVID-19. NiRCoV Study: Correspondence

Authors:

HDH. Daungsupawong
H. Daungsupawong

Publisher website

27 March 2025

journal article
Published by Elsevier in Medicina de Familia. SEMERGEN

Vol. 51 (6) , 102485
DOI:10.1016/j.semerg.2025.102485
PMID:40147108

Abstract

No abstract available

This publication has 1 reference indexed in Scilit:

Efectividad y seguridad de nirmatrelvir + ritonavir en la Covid-19. Estudio NiRCoV
Medicina de Familia. SEMERGEN, 2025